Skip to main content
OpenTrials
Completed

NCT Number: NCT04633759

Low Load Resistance Training Using Blood Flow Restriction for People With Multiple Sclerosis

The Primary Aim of this research study is to determine the feasibility of 8 weeks of physical therapy strengthening exercises using blood flow restriction (BFR) in people with multiple sclerosis (MS) who have moderate-to-severe walking problems. BFR training involves placing a cuff on the leg being exercised in order to restrict blood flow. The cuff is attached to a specialized device that automatically detects the appropriate amount of pressure to place on the limb. Testing will occur before and after the 8-week treatment period.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Colorado

Aurora, Colorado, 80045, United States

About this study

The Primary Aim of this research study is to determine the feasibility of 8 weeks of physical therapy strengthening exercises using blood flow restriction (BFR) in people with multiple sclerosis (MS) who have moderate-to-severe walking problems. BFR training involves placing a cuff on the leg being exercised in order to restrict blood flow. The cuff is attached to a specialized device that automatically detects the appropriate amount of pressure to place on the limb. Testing will occur before and after the 8-week treatment period.

Specific Aim 1: Determine the feasibility of BFR by assessing recruitment rate, retention, adherence, satisfaction, and safety.

Hypothesis: Feasibility will be demonstrated by: 1) enrolling 20 participants in 8 months, 2) retaining at least 16 (80%) participants, 3) 80% adherence to intervention, 4) 90% satisfaction with intervention, and 5) no serious adverse events related to the intervention.

Specific Aim 2: Determine changes in knee and hip extension, hip abduction, and ankle plantarflexion muscle strength after the 8-week intervention.

Hypothesis: Following intervention there will be clinically important within-group strength changes that correspond to established minimal detectable change values and which can be characterized as having at least a moderate effect size as defined by Cohen's d.

Exploratory Aim: Explore changes in functional mobility (30-Second Sit-to-Stand, Berg Balance Scale, Timed 25-Foot Walk. 10-day average activity level) and self-report measures (12-Item MS Walking Scale, Modified Fatigue Impact Scale, MS Impact Scale-29, and Patient-Specific Functional Scale) after the 8-week intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults ages 18-70
  • Neurologist-confirmed diagnosis of multiple sclerosis
  • Expanded Disability Status Scale (EDSS) 6.0 to 7.0
  • EDSS 6.0: unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting
  • EDSS 6.5: Bilateral assistance (cane or crutch) required to walk at least 20 meters with or without resting
  • EDSS 7.0: unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day

Exclusion criteria

  • EDSS 7.5 or greater: Restricted to wheelchair for all mobility, unable to walk more than a few steps, even with walking aid
  • EDSS 5.5 or less: Able to walk more than 100 meters without walking aid or rest
  • Unable to provide consent or follow simple directions
  • Prior history of Deep Venous Thrombosis/ Pulmonary Embolism
  • History of peripheral vascular disease, thrombophilia or other clotting disorders
  • Patient report of easy bruising
  • Any comorbid conditions or pain that substantially affects physical function or would interfere with the participant's ability to safely complete rehabilitation (e.g. neurologic, vascular, cardiac problems, orthopedic, or ongoing medical treatments) as determined by a neurologist of physical therapist
  • Severe lower extremity spasticity as defined as Modified Ashworth scale > 2
  • Currently undergoing supervised resistance training with a physical therapist or other exercise professional
  • Use of Blood Flow Restriction currently or in the previous 3 months prior to enrollment
  • MS-related exacerbation or changes to their disease-modifying drug therapy in the month prior to enrollment
  • Inability to tolerate pressure cuff during baseline assessment

Treatment and study plan

blood flow restriction exercise

Other

Following a 5-minute low intensity warm-up, the BFR cuff will be placed at the most proximal portion of the leg and dosed following standard BFR guidelines: 1 set of 30 reps, then 3 sets of 15 reps at 20-30% 1RM with up to 80% limb occlusion. Exercises will target bilateral 1) knee and hip extension, 2) hip abduction, and 3) ankle plantarflexion, as these muscles are important for functional mobility in people with MS.

Primary outcomes

  1. Change in Knee Extension Muscle Strength (More-involved Side)

    Time frame: Measured at Baseline (Week 0) and Post Test (Week 9)

    Knee extension muscle strength measured by hand-held dynamometry on the more-involved side. The more-involved limb was determined at baseline assessment and defined as the limb with worse muscle strength.

  2. Change in Hip Abduction Muscle Strength (More-involved Side)

    Time frame: Measured at Baseline (Week 0) and Post Test (Week 9)

    Hip abduction muscle strength measured by hand-held dynamometry on the more-involved side. The more-involved limb was determined at baseline assessment and defined as the limb with worse muscle strength.

  3. Change in Ankle Plantarflexion Muscle Strength (More-involved Side)

    Time frame: Measured at Baseline (Week 0) and Post Test (Week 9)

    Ankle plantarflexion muscle strength measured by hand-held dynamometry on the more-involved side. The more-involved limb was determined at baseline assessment and defined as the limb with worse muscle strength.

  4. Change in Knee Extension Muscle Strength (Less-involved Side)

    Time frame: Measured at Baseline (Week 0) and Post Test (Week 9)

    Knee extension muscle strength measured by hand-held dynamometry on the less-involved side. The less-involved limb was determined at baseline assessment and defined as the limb with better muscle strength.

  5. Change in Hip Abduction Muscle Strength (Less-involved Side)

    Time frame: Measured at Baseline (Week 0) and Post Test (Week 9)

    Hip abduction muscle strength measured by hand-held dynamometry on the less-involved side. The less-involved limb was determined at baseline assessment and defined as the limb with better muscle strength.

  6. Change in Ankle Plantarflexion Muscle Strength (Less-involved Side)

    Time frame: Measured at Baseline (Week 0) and Post Test (Week 9)

    Ankle plantarflexion muscle strength measured by hand-held dynamometry on the less-involved side. The less-involved limb was determined at baseline assessment and defined as the limb with better muscle strength.

Secondary outcomes

  1. Change in 30-second Sit-to-stand Completions

    Time frame: Measured at Baseline (Week 0) and Post Test (Week 9)

    Functional mobility test measuring the number of sit to stand cycles a participant can complete in 30 seconds

  2. Change in Berg Balance Scale

    Time frame: Measured at Baseline (Week 0) and Post Test (Week 9)

    Functional mobility test measuring the participant's ability to balance in different postures. Scores on the Berg Balance Scale range from 0 to 56 points, with 0-20 points indicating wheelchair bound, 21-40 indicating walking with assistance, and 41-56 indicating walking independently.

  3. Change in Timed 25-foot Walk

    Time frame: Measured at Baseline (Week 0) and Post Test (Week 9)

    Functional mobility test measuring the time it takes a participant to walk 25 feet

  4. Change in Activity Level

    Time frame: Measured at Baseline (Week 0) and Post Test (Week 9)

    10-day average of activity level as measured by a wearable activity monitor

  5. Change in 12-Item MS Walking Scale

    Time frame: Measured at Baseline (Week 0) and Post Test (Week 9)

    Self-report questionnaire measuring walking ability with scores ranging from 12 points (no difficulty walking, to 60 points (extremely limited or no walking)

  6. Change in Modified Fatigue Impact Scale

    Time frame: Measured at Baseline (Week 0) and Post Test (Week 9)

    Self-report questionnaire measuring fatigue caused by MS with scores ranging from 0 (no impact of fatigue in the past 4 weeks) to 84 (maximum impact of fatigue in the past 4 weeks)

  7. Change in MS Patient-Specific Function Scale

    Time frame: Measured at Baseline (Week 0) and Post Test (Week 9)

    Self-report questionnaire measuring the ability of the participant to do three self-identified activities. Scores of each of the 3 activities range from 0 (unable to perform) to 10 (able to perform without difficulty). The score is the average of the 3 activities, with higher scores indicating better function.

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Collaborators

  • Consortium of Multiple Sclerosis Centers

Registry information

Official study title

Feasibility of Low-load Resistance Training Using Blood Flow Restriction for People With Multiple Sclerosis and Marked Mobility Restriction

Acronym: BFR-MS

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Nov 18, 2020
Registry last updated
Jun 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.